| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 30, 2005
From the Department of Neurology (E.E.S., A.R.A., W.J.K., L.H.S.), Massachusetts General Hospital, Boston; the Department of Radiological Sciences (I.P.), UCLA, Los Angeles, Calif; and the Department of Internal Medicine (E.R.), Beth Israel-Deaconess Medical Center, Boston, Mass. * To whom correspondence should be addressed. E-mail: eesmith{at}partners.org.
Background and Purpose--Some patients with mild or improving ischemic stroke symptoms do not receive intravenous tissue plasminogen activator (tPA) because they look "too good to treat" (TGT); however, some have poor outcomes. Methods--We retrospectively analyzed data from a prospective single-center study between 2002 and 2004. TGT patients were those arriving within 3 hours of symptom onset and not treated with intravenous tPA solely because of mild or improving symptoms. Results--Of 128 patients presenting within 3 hours, 41 (34%) were not given tPA because of mild or improving stroke. Of the TGT patients, 11 of 41 (27%) died or were not discharged home because of neurological worsening (n=6) or persistent "mild" neurological deficit (n=5). No single variable at presentation was associated with death or lack of home discharge. There were 10 of 41 TGT patients (24%) who had Conclusion--A substantial minority of patients deemed too good for intravenous tPA were unable to be discharged home. A re-evaluation of the stroke severity criteria for tPA eligibility may be indicated.
Accepted on July 18, 2005
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Eric E. Smith MD, FRCPC*;
4-point improvement in National Institutes of Health Stroke Scale score before tPA decision; these patients were more likely to have subsequent neurological worsening (relative risk, 4.1, 95% CI, 1.1 to 15.4; P=0.05).
This article has been cited by other articles:
![]() |
A Kruetzelmann, S Siemonsen, C Gerloff, M Rosenkranz, J Rother, J Fiehler, and G Thomalla Thrombolysis targeting MRI defined tissue at risk in minor stroke J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1156 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Cho, M. Hermier, J. A. Alawneh, T. Ritzenthaler, V. Desestret, L. Ostergaard, L. Derex, J.-C. Baron, and N. Nighoghossian Total Mismatch: Negative Diffusion-Weighted Imaging but Extensive Perfusion Defect in Acute Stroke Stroke, October 1, 2009; 40(10): 3400 - 3402. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Puetz, I. Dzialowski, S. B. Coutts, M. D. Hill, A. Krol, C. O'Reilly, M. Goyal, A. M. Demchuk, and for the Calgary CTA Study Group Frequency and Clinical Course of Stroke and Transient Ischemic Attack Patients With Intracranial Nonocclusive Thrombus on Computed Tomographic Angiography Stroke, January 1, 2009; 40(1): 193 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, K. Toyoda, T. Uehara, N. Toratani, C. Yokota, H. Moriwaki, H. Naritomi, and K. Minematsu Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes Neurology, June 10, 2008; 70(24_Part_2): 2371 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. De Keyser, Z. Gdovinova, M. Uyttenboogaart, P. C. Vroomen, and G. J. Luijckx Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations Stroke, September 1, 2007; 38(9): 2612 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nedeltchev, B. Schwegler, T. Haefeli, C. Brekenfeld, J. Gralla, U. Fischer, M. Arnold, L. Remonda, G. Schroth, and H. P. Mattle Outcome of Stroke With Mild or Rapidly Improving Symptoms Stroke, September 1, 2007; 38(9): 2531 - 2535. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dirks, L. W Niessen, P. J Koudstaal, C. L Franke, R. J van Oostenbrugge, D. W J Dippel, and the members of the Delphi panel on indications and Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 685 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aleu, P. Mellado, C. Lichy, M. Kohrmann, and P. D. Schellinger Hemorrhagic Complications After Off-Label Thrombolysis for Ischemic Stroke Stroke, February 1, 2007; 38(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Thomas, L. H. Schwamm, and M. H. Lev Case records of the Massachusetts General Hospital. Case 16-2006. A 72-year-old woman admitted to the emergency department because of a sudden change in mental status. N. Engl. J. Med., May 25, 2006; 354(21): 2263 - 2271. [Full Text] [PDF] |
||||
![]() |
C. R. Baumann, R. W. Baumgartner, J. Gandjour, H.-C. von Budingen, A. M. Siegel, and D. Georgiadis Good Outcomes in Ischemic Stroke Patients Treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms Stroke, May 1, 2006; 37(5): 1332 - 1333. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |